
|Articles|February 1, 2008
Insomnia drug should be classified under Schedule IV, DEA says
Drug Enforcement Administration proposes placing indiplon in Schedule IV
Advertisement
The Drug Enforcement Administration has proposed placing
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Oral GLP-1 Medication Will Impact the Patient Medication Journey
2
Maternal Health Awareness Day: Advocacy, Policy Crucial for Protecting Access to Maternal Health
3
Congressional Spending Bill to Include Key PBM Contracting Reform
4
IRA Drug Price Negotiations Threatening Pharmacies’ Financial Sustainability
5
















